UNSPSC 51412300: Vasodilator benzofurans

Vasodilator drugs made from

UNSPSC 51412300 Vasodilator benzofurans is a Class code for specific pharmaceutical active ingredients and formulations used in emergency medical and acute care settings. State and local governments procure these medications primarily through fire rescue departments, emergency medical services, hospital systems, and state health agencies, typically as part of Advanced Life Support (ALS) medication supply contracts. The work involves supplying pre-filled vials, injections, and other ready-to-dispense formulations that meet strict expiration, quality, and compliance standards, including OSHA Safety Data Sheet requirements, FDA approval, and chain-of-custody documentation. Issuing bodies include municipal fire departments (like the City of Tampa Fire Rescue), state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions and their subordinate facilities.

Recent activity shows geographic spread across Florida, Texas, and the Upper Midwest. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026, estimated value $40,000) for Tampa Fire Rescue, specifying four medication line items including Labetalol, Epinephrine, Adenosine, and Diltiazem with nine-month minimum shelf life and ten-calendar-day delivery windows. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013) in April 2026 regarding direct-to-manufacturer prescription programs, signaling potential future state-level procurement activity beyond traditional wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed to participating state and local facilities across Minnesota and Oregon, with product availability required by May 15, 2026 and contract effectiveness July 1, 2026. MMCAP's evaluation weights price competitiveness at 75 percent and requires vendors to maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and comply with cGMP and Drug Supply Chain Security Act standards.